Want to join the conversation?
$AVY has updated FY15 EPS guidance to $2.80-2.90, reflecting an increase in estimated restructuring charges. Excluding an estimated $0.50 per share for restructuring costs and other items, $AVY has narrowed its expectations for FY15 adjusted earnings per share to $3.30 to $3.40.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?